103 | A PHASE 1 STUDY OF KITE‐363 ANTI‐CD19/CD20 CHIMERIC ANTIGEN RECEPTOR (CAR) T‐CELL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) B‐CELL LYMPHOMA. - Dahiya, S.; Ulrickson, M. L.; Topp, M. S.; Kersten, M. J.; Yared, J.; Reagan, P. M.; Reshef, R.; Sanderson, R.; Voorhees, T.; Ahmed, S.; Jung, A. S.; Granados, E.; et al. (Hematological oncology, 2025)